Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 10.68B P/E 30.62 EPS this Y 1.90% Ern Qtrly Grth 9.90%
Income 341.3M Forward P/E 20.37 EPS next Y 9.50% 50D Avg Chg 2.00%
Sales 1.97B PEG 12.20 EPS past 5Y 9.73% 200D Avg Chg -
Dividend N/A Price/Book 3.00 EPS next 5Y 1.66% 52W High Chg -8.00%
Recommedations 2.30 Quick Ratio 1.44 Shares Outstanding 221.36M 52W Low Chg 16.00%
Insider Own 0.42% ROA 4.49% Shares Float 219.40M Beta 0.41
Inst Own 75.13% ROE 9.38% Shares Shorted/Prior 3.29M/3.16M Price 46.85
Gross Margin 66.04% Profit Margin 17.37% Avg. Volume 1,063,970 Target Price 51.05
Oper. Margin 23.86% Earnings Date May 1 Volume 1,337,509 Change 0.06%
About Qiagen N.V.

QIAGEN N.V. offers sample to insight solutions that transform biological materials into molecular insights worldwide. The company provides primary sample technology consumables, such as nucleic stabilization and purification kits for primary sample materials, manual and automated processing for genotyping, gene expression, and viral and bacterial analysis, as well as silica membranes and magnetic bead technologies; secondary sample technology consumables, including kits and components for purification of nucleic acids from secondary sample materials; and instruments for nucleic acid purification and accessories. It also provides interferon-gamma release assay for TB testing, and assays for post-transplant testing and viral load monitoring; assays for prenatal testing and detection of sexually transmitted diseases and HPV, as well as assays for analysis of genomic variants, such as mutations, insertions, deletions, and fusions; and sample to insight instruments, including one-step molecular analysis of hard-to-diagnose syndromes, and integrated PCR testing. In addition, it offers PCR consumables, such as quantitative PCR, reverse transcription, and combinations kits for analysis of gene expression, genotyping and gene regulation, and running on QIAGEN instruments and technologies; human ID and forensics assay consumables, including STR assays for human ID, and assays for food contamination; PCR instruments consist of digital PCR and qPCR solutions; and developed and configured enzymes and PCR solutions. Further, the company provides predefined and custom NGS gene panels, library prep kits and components, and whole genome amplification; QIAGEN consumables and instruments, as well as bioinformatics solutions; and custom laboratory and genomic services. It serves molecular diagnostics, academia, pharmaceutical, and applied testing customers. The company was founded in 1984 and is headquartered in Venlo, the Netherlands.

Qiagen N.V. News
03/26/24 QIAGEN (QGEN) Unveils QIAstat-Dx Analyzer With Remote Access
03/25/24 QIAGEN introduces QIAstat-Dx Analyzer 2.0 with remote test results access, enhancing collaboration across healthcare system
03/25/24 QIAGEN (QGEN) Partners With IPPA to Raise TB Screening Awareness
03/25/24 Labcorp (LH) Boost Diagnostics Suite With New Biomarker Test
03/21/24 Has Qiagen N.V. (NYSE:QGEN) Stock's Recent Performance Got Anything to Do With Its Financial Health?
03/18/24 QIAGEN partners with International Panel Physicians Association to increase awareness of tuberculosis screening requirements
03/14/24 Why Is Incyte (INCY) Up 1.8% Since Last Earnings Report?
03/11/24 QIAGEN announces Form 20-F annual report filing for 2023 results
03/07/24 Qiagen (QGEN) Up 1.1% Since Last Earnings Report: Can It Continue?
03/04/24 QIAGEN (QGEN) Launches AI-Driven Biomedical Knowledge Base
12:30 PM Qiagen N.V. (NYSE:QGEN) is largely controlled by institutional shareholders who own 81% of the company
02/27/24 QIAGEN launches AI-derived biomedical knowledge base to accelerate data-driven drug discovery
02/27/24 QIAGEN earns ACT Label for new eco-friendlier QIAwave products and achieves first My Green Lab Platinum certification
02/19/24 QIAGEN (QGEN) Earns Notable Recognitions in Sustainability
02/13/24 Qiagen N.V. (NYSE:QGEN) Q4 2023 Earnings Call Transcript
02/09/24 The Qiagen N.V. (NYSE:QGEN) Full-Year Results Are Out And Analysts Have Published New Forecasts
02/07/24 QIAGEN (QGEN) Q4 Earnings Miss, Operating Margin Expands
02/06/24 Qiagen (QGEN) Reports Q4 Earnings: What Key Metrics Have to Say
02/06/24 QIAGEN exceeds outlook for Q4 2023, led by 8% CER sales growth in non-COVID products and improved operational profitability
01/31/24 QIAGEN (QGEN) Forges Alliance to Advance Microbiome Sciences
QGEN Chatroom

User Image Stock_Titan Posted - 3 days ago

$QGEN QIAGEN introduces QIAstat-Dx Analyzer 2.0 with remote test results access, enhancing collaboration across healthcare system https://www.stocktitan.net/news/QGEN/qiagen-introduces-qi-astat-dx-analyzer-2-0-with-remote-test-results-4yzybqkhag9n.html

User Image DailyStocksPicks Posted - 1 week ago

Today's Oversold Stock #4: Cabaletta Bio ($SHC): Sotera Health provides sterilization solutions, lab testing, and advisory services for the healthcare industry. Recently, it's faced challenges such as a secondary stock offering, insider selling, and disappointing earnings, which have pressured its stock price. These developments suggest the stock could be considered oversold, with the market potentially underestimating Sotera Health's value in its sector despite current challenges. $PGNY, $RDNT, $QGEN, $FMS For Detailed https://youtu.be/kiXj5yPn9rc

User Image Stock_Titan Posted - 1 week ago

$QGEN QIAGEN partners with International Panel Physicians Association to increase awareness of tuberculosis screening requirements https://www.stocktitan.net/news/QGEN/qiagen-partners-with-international-panel-physicians-association-to-y0b6b25tlgqf.html

User Image Stock_Titan Posted - 2 weeks ago

$QGEN QIAGEN announces Form 20-F annual report filing for 2023 results https://www.stocktitan.net/news/QGEN/qiagen-announces-form-20-f-annual-report-filing-for-2023-8ou51947wad9.html

User Image TickerDD_com Posted - 3 weeks ago

From 2/28/2024, looking back across 22 Month-Ends for QGEN, Percentage Change of Average Monthly Price had Equal (50%) while Percentage Change of Average Monthly Volume had All Positives (100%) $QGEN #QGEN #QGENStock #TickerDD #QGENPrice https://www.youtube.com/watch?v=4QQySNPFTXs

User Image Stock_Titan Posted - 1 month ago

$QGEN QIAGEN launches AI-derived biomedical knowledge base to accelerate data-driven drug discovery https://www.stocktitan.net/news/QGEN/qiagen-launches-ai-derived-biomedical-knowledge-base-to-accelerate-unm40eohevcj.html

User Image Stock_Titan Posted - 1 month ago

$QGEN QIAGEN earns ACT Label for new eco-friendlier QIAwave products and achieves first My Green Lab Platinum certification https://www.stocktitan.net/news/QGEN/qiagen-earns-act-label-for-new-eco-friendlier-qi-awave-products-and-zl1i145lyudd.html

User Image swingingtech Posted - 1 month ago

$QGEN $SYK $CAH $DVA https://wallstreetwaves.com/qiagen-qgen-earns-notable-recognitions-in-sustainability/

User Image Stock_Titan Posted - 1 month ago

$QGEN QIAGEN earns ACT Label for new eco-friendlier QIAwave products and achieves first My Green Lab Platinum certification https://www.stocktitan.net/news/QGEN/qiagen-earns-act-label-for-new-eco-friendlier-qi-awave-products-and-99pf53xk3m6x.html

User Image Thestocktraderhubzee Posted - 1 month ago

WATCHLIST FEB 09 2024. $QGEN JP Morgan Maintains Overweight on Qiagen, Raises Price Target to $52 $CFLT JP Morgan Maintains Neutral on Confluent, Raises Price Target to $27 $RXO RXO shares are trading lower after the company reported worse-than-expected Q4 revenue results. Also, B of A Securities downgraded the stock from Buy to Neutral and lowered its price target from $25 to $22. $BBD Banco Bradesco shares are trading lower after Goldman Sachs maintained a Sell rating on the stock and lowered its price target from $3.2 to $2.8. $VERU HC Wainwright & Co. Reiterates Buy on Veru, Maintains $2 Price Target

User Image Thestocktraderhubzee Posted - 1 month ago

$QGEN Citigroup Maintains Buy on Qiagen, Lowers Price Target to $60

User Image epsguid Posted - 1 month ago

$QGEN reported earnings of $0.55, consensus was $0.56 via @eWhispers #epsmiss http://eps.sh/d/qgen

User Image Stock_Titan Posted - 1 month ago

$QGEN QIAGEN exceeds outlook for Q4 2023, led by 8% CER sales growth in non-COVID products and improved operational profitability https://www.stocktitan.net/news/QGEN/qiagen-exceeds-outlook-for-q4-2023-led-by-8-cer-sales-growth-in-non-e4l1l7qxl2mv.html

User Image JEDI_2023 Posted - 1 month ago

$QGEN Interesting synthetic reverse split for $1.25 cash per share (reads like manipulation). Why not just start paying a dividend?

User Image AshtonBergman Posted - 1 month ago

$IHS $QGEN $HIMS Analyst price target for today[- https://live-alerts-stock-trades.topmarketwatch.vip

User Image KevMomentum Posted - 1 month ago

MORNING RECAP // SMALL GREEN DAY $QGEN 44.40 - 44.70 // +.5R QGEN 44.10 - 45.20+ // +2.75R $CVNA 47.25 - 47.90+ // +1R $SPOT 246.20 - 247.70 // +1R SPOT 246 - 241 // -1R 🔻 3.73 profit factor 75% winrate stay disciplined until the market is hot again!

User Image cctranscripts Posted - 2 months ago

BlackRock, Inc. just provided an update on share ownership of Qiagen N.V. https://www.conferencecalltranscripts.org/summary/?id=12887777 $QGEN

User Image risenhoover Posted - 2 months ago

$QGEN / Qiagen N.V. files form 6-K https://fintel.io/doc/sec-qiagen-nv-1015820-6k-2024-january-23-19745-5229?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=filing

User Image ChartMill Posted - 2 months ago

In the last couple of years the Gross Margin of $QGEN has remained more or less at the same level. https://www.chartmill.com/stock/quote/QGEN/fundamental-analysis?key=d66d481e-ce54-4c3b-babd-7ab846e1382f&utm_source=PROFITABILITY&utm_medium=stocktwits&utm_campaign=FA&utm_content=QGEN

User Image ChartMill Posted - 2 months ago

$LUNG, $GNK, $LECO, $QGEN and $PK are being bought by large players and show a pocket pivot signal today. https://www.chartmill.com/stock/stock-screener?sid=31&f=smlev20v_b_lev,smlev20v_r,p_pg10,pp_1,v1_50b200,cu_a_sm50v,der5_a_0.03,s_ppt,exch_us&v=3&timeframe=DAILY&type=CANDLES&o1=17&op1=10%252C2,16711680&i1=49&ia1=on&cl=F&months=0.05&o2=3&op2=50,255&width=720&o3=3&op3=10,65280&utm_source=large_effective_volume_+_pocket_pivot_today&utm_medium=stocktwits&utm_campaign=screen

User Image STCKPRO Posted - 2 months ago

$QGEN NEW ARTICLE : QIAGEN announces details for completion of synthetic share repurchase of up to approximately $300 million https://stck.pro/news/QGEN/73095398/

User Image DonCorleone77 Posted - 2 months ago

$QGEN Qiagen announces details for completion of share repurchase up to $300M Qiagen announced details for completion of the synthetic share repurchase plan to return up to approximately $300M that combines a direct capital repayment to QIAGEN shareholders with a reverse stock split. The repayment from existing cash reserves is expected to lead to an approximately 3% reduction in the number of issued shares The terms of the synthetic share repurchase are as follows: Every 25 issued QIAGEN shares will be consolidated into 24.25 QIAGEN shares, leading to a reduction of approximately 6.9 million shares from the level of 230.8 million shares at the end of 2023. Following the implementation of the consolidation, QIAGEN will repay capital to shareholders of record in the amount of $1.28 per pre-split share. The last day of trading of the pre-split shares on the New York Stock Exchange and the Frankfurt Stock Exchange is planned to be Monday, January 29, 2024. Beginning on January 30.

User Image STCKPRO Posted - 2 months ago

$QGEN NEW ARTICLE : Berenberg Bank Remains a Buy on Qiagen (QGEN) https://stck.pro/news/QGEN/73071640/

User Image TrendyChart Posted - 2 months ago

$QGEN Melody of gains on harmonious chart. 🚀 https://trendychart.lpages.co/options/

User Image UltraAlgo Posted - 2 months ago

$QGEN Buy Rating from 10 signals, 15-min ticks 🚀 Chart by UltraAlgo https://i.redd.it/5mllri54xtcc1.png

User Image TrendyChart Posted - 2 months ago

$QGEN Mosaic of possibilities on stable chart. 🏰 https://trendspider.com/?_go=options

User Image TrendyChart Posted - 2 months ago

$QGEN The canvas of the stock chart is adorned with bullish strokes, as technical indicators shape a narrative of potential success and strong support that secures its foundation, promising financial prosperity. 🚀 https://trendspider.com/?_go=options

User Image Stock_Titan Posted - 2 months ago

$QGEN QIAGEN N.V. to release results for Q4 2023 and hold webcast https://www.stocktitan.net/news/QGEN/qiagen-n-v-to-release-results-for-q4-2023-and-hold-uejjuvbsi82e.html

User Image tickeron Posted - 2 months ago

Do you agree with the A.I. prediction? $QGEN The volume increased for four consecutive days, resulting in a record-breaking daily growth of 107% of the 65-Day Volume Moving Average. View odds of downtrend. https://srnk.us/go/4964457

User Image StockAutomatePro Posted - 2 months ago

$QGEN The chart suggests a bullish outlook for the stock. We alerted the BUY signal at $43.56 and we were able to close this one with profit at $45.27 📊 See more details at StockAutomate.com